Abstract
Rabbit antimouse thymocyte (RAMT) serum, a potent suppressant of cell-mediated immunity (1), has been shown to affect the course of several viral infections in mice (2). The effect of RAMT serum on herpesvirus hominis (HVH) infection was considered of particular interest since certain clinical conditions associated with defects in the thymus-dependent cellular immune system, such as the Wiskott-Aldrich syndrome (3) may develop severe, even fatal, HVH infections. It was also desirable to ascertain if the effect of RAMT serum would depend on the route of HVH inoculation, since this was an important factor in the case of primary vaccinia infection in mice (4).Materials and Methods. Virus strain. Earlier studies in adult mice demonstrated that neurovirulence of HVH strains depended on their antigenic type; HVH type 2 is more virulent than HVH type 1 whether inoculated intragenitally, intramuscularly, or intracerebrally (5, 6). Since all 28 HVH strains isolated from the brain or spinal fluid of patients, other...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
